Cerora, Inc.’s product, Cerora Qumpass, is creating cutting-edge advancements
The rapid diagnosis of brain disease and injuries can lead to early and effective intervention with resulting cost savings, improved clinical outcomes, and increased patient satisfaction for people with concussions/traumatic brain injury, Parkinson’s disease, Alzheimer’s disease, and other neurologic and psychiatric conditions. There are currently no affordable, portable, and accurate neuro-diagnostics available to physicians, nurses, first responders, and trainers for use in real time.
Cerora Inc.’s first product, Cerora Qumpass™, is a cloud-based software as a service medical-grade, neurodiagnostic solution. The company’s MindReader™ is a portable electroencephalogram (EEG) brain wave biosensor that measures the electrical activity of the brain. It combines cutting-edge advancements in EEG design with cognitive and voice-based data streams, all integrated with software to provide real-time, objective neurodiagnostic information in the field.